CS545686A1 - Farmaceuticky prostredek a antihepatotoxickym pusobenim - Google Patents
Farmaceuticky prostredek a antihepatotoxickym pusobenimInfo
- Publication number
- CS545686A1 CS545686A1 CS865456A CS545686A CS545686A1 CS 545686 A1 CS545686 A1 CS 545686A1 CS 865456 A CS865456 A CS 865456A CS 545686 A CS545686 A CS 545686A CS 545686 A1 CS545686 A1 CS 545686A1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- flavanolignanes
- phospholipids
- pusobenim
- antihepatotoxickym
- farmaceuticky
- Prior art date
Links
- 150000003904 phospholipids Chemical class 0.000 abstract 3
- 208000030090 Acute Disease Diseases 0.000 abstract 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 208000019423 liver disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 abstract 1
- 229960004245 silymarin Drugs 0.000 abstract 1
- 235000017700 silymarin Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT21603/85A IT1187687B (it) | 1985-07-17 | 1985-07-17 | Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi |
Publications (2)
Publication Number | Publication Date |
---|---|
CS545686A1 true CS545686A1 (en) | 1988-07-15 |
CS261637B1 CS261637B1 (en) | 1989-02-10 |
Family
ID=11184200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS865456A CS261637B1 (en) | 1985-07-17 | 1986-07-17 | Antihepatotoxic pharmaceutical preparat |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0209037B1 (cs) |
JP (1) | JPS6222719A (cs) |
AT (1) | ATE50499T1 (cs) |
CS (1) | CS261637B1 (cs) |
DE (1) | DE3669106D1 (cs) |
IT (1) | IT1187687B (cs) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1190370B (it) * | 1985-06-19 | 1988-02-16 | Zambon Spa | Composizione farmaceutica solida per uso orale |
IT1201149B (it) * | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche |
DE4401902C2 (de) * | 1994-01-24 | 2000-02-03 | Madaus Ag | Verwendung von Flavolignanen als Adjuvans in der Tumortherapie |
DE19501266A1 (de) * | 1995-01-18 | 1996-07-25 | Madaus Ag | Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln |
CN1061239C (zh) * | 1995-01-20 | 2001-01-31 | 李叔文 | 爱滋病特效治疗剂 |
RU2133122C1 (ru) * | 1998-10-14 | 1999-07-20 | Научно-исследовательский институт биомедицинской химии РАМН | Композиция, обладающая свойствами репарировать биологические мембраны |
US6979459B1 (en) | 2000-04-06 | 2005-12-27 | Perricone Nicholas V | Treatment of skin damage using polyenylphosphatidycholine |
US6191121B1 (en) * | 2000-04-06 | 2001-02-20 | Nicholas V. Perricone | Treatment of skin damage using polyenylphosphatidylcholine |
US6932963B2 (en) | 2000-06-23 | 2005-08-23 | Nicholas V. Perricone | Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines |
ES2288193T3 (es) | 2001-07-27 | 2008-01-01 | NEPTUNE TECHNOLOGIES & BIORESSOURCES INC. | Fosfolipidos naturales de origen marino que contienen flavonoides y fosfolipidos poliinsaturados y sus usos. |
WO2003035087A1 (en) * | 2001-10-25 | 2003-05-01 | Vladimir Leko | Composition for protection and regeneration of structure and function of the liver |
US20050130937A1 (en) | 2003-10-22 | 2005-06-16 | Enzymotec Ltd. | Lipids containing omega-3 and omega-6 fatty acids |
US8052992B2 (en) | 2003-10-22 | 2011-11-08 | Enzymotec Ltd. | Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions |
US7935365B2 (en) | 2003-10-22 | 2011-05-03 | Enzymotec, Ltd. | Glycerophospholipids for the improvement of cognitive functions |
RU2283114C1 (ru) * | 2005-06-07 | 2006-09-10 | Открытое акционерное общество "Нижегородский химико-фармацевтический завод" | Композиция, обладающая гепатопротекторной активностью и нормализующая обменные процессы |
EP2445472B1 (de) | 2009-06-24 | 2017-12-27 | Lipoid GmbH | Zusammensetzung für kosmetische, pharmazeutische oder diätetische anwendungen |
ES2663714T3 (es) | 2009-10-29 | 2018-04-16 | Acasti Pharma Inc | Composiciones terapéuticas concentradas en fosfolípidos |
CN105816422B (zh) | 2015-01-05 | 2020-08-14 | 天士力医药集团股份有限公司 | 一种水飞蓟宾注射剂及其制备方法 |
CN105983016B (zh) | 2015-03-23 | 2023-08-11 | 天士力医药集团股份有限公司 | 一种含有水飞蓟宾的药物组合 |
CN105983013A (zh) * | 2015-03-23 | 2016-10-05 | 天士力制药集团股份有限公司 | 一种含有水飞蓟宾、葛根提取物的药物组合物 |
ITUB20155532A1 (it) * | 2015-11-12 | 2017-05-12 | St Biochimico Italiano Giovanni Lorenzini Spa | Formulazione farmaceutica orale comprendente silibina |
WO2019087084A1 (en) | 2017-11-02 | 2019-05-09 | Eman Biodiscoveries Sd. Bhd. | Extract of orthosiphon stamineus, formulations, and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR5060M (cs) * | 1965-12-22 | 1967-05-08 | ||
FR2343481A1 (fr) * | 1976-03-11 | 1977-10-07 | Gerlich Norbert | Composition destinee a empecher les lesions des membranes biologiques et a regenerer ces membranes une fois qu'elles ont ete endommagees |
-
1985
- 1985-07-17 IT IT21603/85A patent/IT1187687B/it active
-
1986
- 1986-07-07 DE DE8686109256T patent/DE3669106D1/de not_active Expired - Lifetime
- 1986-07-07 EP EP86109256A patent/EP0209037B1/en not_active Expired - Lifetime
- 1986-07-07 AT AT86109256T patent/ATE50499T1/de not_active IP Right Cessation
- 1986-07-16 JP JP61167749A patent/JPS6222719A/ja active Pending
- 1986-07-17 CS CS865456A patent/CS261637B1/cs unknown
Also Published As
Publication number | Publication date |
---|---|
CS261637B1 (en) | 1989-02-10 |
DE3669106D1 (de) | 1990-04-05 |
JPS6222719A (ja) | 1987-01-30 |
IT8521603A0 (it) | 1985-07-17 |
IT1187687B (it) | 1987-12-23 |
EP0209037A1 (en) | 1987-01-21 |
ATE50499T1 (de) | 1990-03-15 |
EP0209037B1 (en) | 1990-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS545686A1 (en) | Farmaceuticky prostredek a antihepatotoxickym pusobenim | |
IE862554L (en) | Pharmaceutical compositions | |
ATE211387T1 (de) | Oral 1alpha-hydroxyprevitamin d | |
MY118371A (en) | Tetrahydrolipstatin containing compositions | |
CS653586A3 (en) | Pharmaceutical containing 7-isopropoxyisoflavone | |
EP0552256A4 (cs) | ||
NZ226923A (en) | 5'-deoxy-5-fluorocytidine derivatives and pharmaceutical compositions | |
IT1177152B (it) | Procedimento e composizione per la preparazione di prodotti farmaceutici ad azione prolungata controllata per la somministrazione orale | |
SE8402560D0 (sv) | Farmaceutisk komposition | |
EP0513702A3 (en) | Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication | |
IL91069A (en) | Intravenous pharmaceutical compositions and their preparation | |
GB8623557D0 (en) | Therapeutic agents | |
AU1578688A (en) | Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines | |
NZ215186A (en) | 13 alkoxymethoxy avermectin derivatives and pharmaceutical compositions | |
ZA898667B (en) | Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment | |
NZ218749A (en) | 5 to 8-membered azacyclic derivatives and pharmaceutical compositions | |
IL78336A (en) | Compositions for delivery of orally administered fat-soluble drugs | |
GR1000419B (el) | Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου. | |
DK0437294T3 (da) | Orale farmaceutiske præparater i enhedsdosisform | |
GR3032874T3 (en) | Gel-like pharmaceutical compositions containing chondroitin sulfate salts suitable for oral administration | |
EP0438147A3 (en) | Pharmaceutical compositions and dosage forms for the oral administration of calcitonin | |
NZ226516A (en) | 2,2 dimethylchromene derivatives and pharmaceutical compositions | |
ATE110274T1 (de) | Mittel zur verbesserung spezifischer eigenschaften des blutes. | |
TW263437B (cs) | ||
GB8719670D0 (en) | Pharmaceutical compositions |